Inflammatory Bowel Disease Series: Inflammatory Bowel Disease in Special Populations: The Elderly, Obese and LGBTQ Patient
Mayo Clinic Talks17 Heinä 2025

Inflammatory Bowel Disease Series: Inflammatory Bowel Disease in Special Populations: The Elderly, Obese and LGBTQ Patient

Host: Darryl S. Chutka, M.D.

Guests: Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S.

This podcast continues our series on inflammatory bowel disease. The topic is important and timely: “Inflammatory Bowel Disease in Special Populations: The Elderly, the Obese and the LGBTQ Patient.” It’s critical that we broaden our perspective in addressing the unique challenges faced by these often-unrecognized population groups. How common is the presentation of inflammatory bowel disease in those over 65? How does age affect the treatments commonly used? Does obesity alter the disease presentation or activity and what are some of the unique challenges our LGBTQ patients face with inflammatory bowel disease? These are just some of the questions I’ll be asking my guests, Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S., both gastroenterologists at the Mayo Clinic.

https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Jaksot(500)

Heart Health Series | Cardiotoxicity of Cancer Therapies

Heart Health Series | Cardiotoxicity of Cancer Therapies

Host: Darryl S. Chutka, M.D.  Guest: Balaji Tamarappoo, M.D., Ph.D.  With advances in oncology, patients are living longer than ever following a diagnosis of cancer. Newer treatments have dramatically...

24 Helmi 26min

Heart Health Series | Pericardial Disease

Heart Health Series | Pericardial Disease

Host: Darryl S. Chutka, M.D.  Guest: Hema Narayanasamy, M.B.B.S.  Pericardial disease represents a spectrum of both inflammatory and non-inflammatory disorders which involve the pericardium, with acut...

17 Helmi 28min

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

The Power of Intervals: High Intensity Interval Training and Reducing Cardiovascular Risk

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  We have a variety of pharmacologic options and lifestyle changes we recommend to our patients to reduce their cardiovascular risks. One freq...

10 Helmi 20min

Heart Health Series | Bicuspid Aortic Valve Disease

Heart Health Series | Bicuspid Aortic Valve Disease

Host: Darryl S. Chutka, M.D.  Guest: George Wang, M.D.  Bicuspid aortic valve is a relatively common congenital heart disease. It can be associated with other genetic disorders such as Turner’s Syndro...

5 Helmi 29min

Heart Health Series | Cardiac Amyloidosis

Heart Health Series | Cardiac Amyloidosis

Host: Darryl S. Chutka, M.D.  Guest: Julie Rosenthal, M.D.  Cardiac amyloidosis is not a common condition, but it is important for primary care clinicians to recognize it in our patients. It’s commonl...

3 Helmi 29min

Concussions: What Every Primary Care Provider Should Know

Concussions: What Every Primary Care Provider Should Know

Host: Darryl S. Chutka, M.D. Guest: Matthew B. Anastasi, M.D. Patients with concussions are commonly seen in primary care practices and concussions don’t spare any particular age group. Children, youn...

27 Tammi 27min

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Rx for Weight Loss: A Closer Look Series "The Wins of Losing: GLP-1 Agonists and Reducing Heart Disease Risk"

Host: Darryl S. Chutka, M.D.  Guest: Stephen Kopecky, M.D.  One of the biggest surprises we’ve seen in medicine in the past several years has been the numerous health benefits realized from the GLP-1 ...

20 Tammi 20min

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Rx for Weight Loss: A Closer Look Series "Controversies & Future of GLP-1 Medications"

Host: Darryl S. Chutka, M.D.  Guests: Tamim I. Rajjo, M.D., M.P.H.; Meera Shah, M.B., Ch.B.  The class of medications known as the GLP-1 agonists is very popular with our patients. Although initially ...

15 Tammi 24min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
adhd-podi
rss-narsisti
rss-rahamania
rss-vapaudu-voimaasi
psykologia
aamukahvilla
rss-liian-kuuma-peruna
rahapuhetta
rss-valo-minussa-2
kesken
jari-sarasvuo-podcast
mielipaivakirja
rss-tietoinen-yhteys-podcast-2
uskonnon-pitka-oppimaara
rss-eron-alkemiaa
rss-koira-haudattuna
rss-arkea-ja-aurinkoa-podcast-espanjasta